HKU ResearcherPage:
Yuen, RMF
Principal Investigator
|
|
Project Code |
Amount |
Title |
Funding Year |
| 1 |
|
HKU 782809M
|
661290 |
Genetic and epigenetic analyses of occult hepatitis B virus infection
|
2009/2010 |
| 2 |
|
09080862
|
699110 |
Virological and clinico-pathological factors in estimating the chance of recurrence of hepatocellular carcinoma after surgical resection in patients with Chronic Hepatitis B
|
2009/2010 |
| 3 |
|
HKU 781108M
|
566592 |
Transmissibility of hepatitis B virus infection from blood donors with occult hepatitis B infection
|
2008/2009 |
| 4 |
|
|
1000000 |
Significance of HBV DNA in the natural history of chronic hepatitis B: impact on disease outcome including significant fibrosis and hepatocellular carcinoma
|
2007/2008 |
| 5 |
|
|
30700 |
A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection
|
2005/2006 |
| 6 |
|
|
107248 |
Randomized, open-label, comparative study to evaluate early viral load reductions and exploratory viral kinetics following administration of entecavir or adefovir in nucleoside-na\x8Bve adults with chronic hepatitis B infection
|
2005/2006 |
| 7 |
|
|
150000 |
An open label study of adefovir dipivoxil for the treatment of patients with chronic hepatitis B (CHB) related advanced fibrosis or cirrhosis
|
2005/2006 |
| 8 |
|
|
430000 |
A phase I/IIa, double-blind, randomized, placebo-controlled study of antiviral agent in patients with chronic hepatitis B infection to investigate the safety, pharmacokinetics and antiviral activity of ascending 4-week oral doses of LB80380
|
2003/2004 |
|
